2m 2m 2m 2m 2m 2m 2m
PULMONX (LUNG)
NASDAQ
$1.53-$0.09 (-5.28%)
Price as of Jun 03, 2026 4:10 PM EDT- $69.7MMarket Cap
- -49.37%1-Year Change
- Medical DevicesIndustry
PULMONX (LUNG)
$1.53-$0.09 (-5.28%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
PRIMECAP MANAGEMENT CO/CA/ | 11.19% | 4.7M | -2,800 (-0.06%) | Mar 31, 2026 |
MORGAN STANLEY | 9.46% | 4.0M | -166,907 (-4.18%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 6.75% | 2.9M | +54,593 (+1.92%) | Dec 31, 2024 |
SOLEUS CAPITAL MANAGEMENT, L.P. | 6.60% | 2.8M | +750,000 (+26.90%) | Mar 31, 2026 |
BLACKROCK INC. | 6.32% | 2.7M | -369,500 (-13.85%) | Jun 30, 2024 |
BLACKROCK, INC. | 6.30% | 2.7M | -44,583 (-1.68%) | Mar 31, 2026 |
VANGUARD GROUP INC | 6.01% | 2.5M | +298,348 (+11.74%) | Dec 31, 2025 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
PRIMECAP Odyssey Funds | 8.53% | 3.6M | -32,400 (-0.90%) | Jan 31, 2026 |
VANGUARD INDEX FUNDS | 3.77% | 1.6M | 0 (0.00%) | Mar 31, 2026 |
iSHARES TRUST | 3.29% | 1.4M | -44,025 (-3.17%) | Mar 31, 2026 |
Advisors' Inner Circle Fund II | 2.73% | 1.2M | 0 (0.00%) | Jan 31, 2026 |
FIDELITY ADVISOR SERIES I | 2.47% | 1.0M | 0 (0.00%) | Jan 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 2.27% | 958,751 | 0 (0.00%) | Feb 28, 2026 |
BlackRock Innovation & Growth Trust | 1.68% | 709,937 | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions624.5M (76.36%)
- Mutual Funds186.9M (22.85%)
- Insiders6.5M (0.79%)
- Other0 (0.00%)
Insider Transactions
- 0.79% (6.5M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 7Number of InsiderSelling (last 12 months)
- $27.4MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
French Glendon E. III President and CEO | Sell | Jun 02, 2026 | $21,212.27 | 13,511 | $1.57 | 1.2M |
Lehman David Aaron GENERAL COUNSEL | Sell | Jun 01, 2026 | $5,969.04 | 3,876 | $1.54 | 386,879 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Jun 01, 2026 | $2,738.12 | 1,778 | $1.54 | 463,956 |
Lehman David Aaron GENERAL COUNSEL | Sell | Jun 01, 2026 | $3,486.56 | 2,264 | $1.54 | 384,615 |
French Glendon E. III President and CEO | Sell | Jun 01, 2026 | $6,423.34 | 4,171 | $1.54 | 1.2M |
Lehman David Aaron GENERAL COUNSEL | Sell | Jun 01, 2026 | $5,450.06 | 3,539 | $1.54 | 381,076 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Jun 01, 2026 | $2,397.78 | 1,557 | $1.54 | 462,399 |
Lehman David Aaron GENERAL COUNSEL | Sell | Jun 01, 2026 | $7,569.10 | 4,915 | $1.54 | 376,161 |
French Glendon E. III President and CEO | Sell | Jun 01, 2026 | $59,239.18 | 38,467 | $1.54 | 1.2M |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Jun 01, 2026 | $3,748.36 | 2,434 | $1.54 | 459,965 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Jun 01, 2026 | $3,471.16 | 2,254 | $1.54 | 457,711 |
Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | Mar 02, 2026 | $1,081.08 | 756 | $1.43 | 180,463 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Mar 02, 2026 | $1,194.05 | 835 | $1.43 | 372,631 |
Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | Mar 02, 2026 | $4,387.24 | 3,068 | $1.43 | 177,395 |
Lehman David Aaron GENERAL COUNSEL | Sell | Mar 02, 2026 | $1,663.09 | 1,163 | $1.43 | 251,829 |
Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | Mar 02, 2026 | $3,519.23 | 2,461 | $1.43 | 174,934 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Mar 02, 2026 | $3,038.75 | 2,125 | $1.43 | 370,506 |
Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | Mar 02, 2026 | $6,003.14 | 4,198 | $1.43 | 170,736 |
French Glendon E. III President and CEO | Sell | Mar 02, 2026 | $3,872.44 | 2,708 | $1.43 | 1.5M |
Radhakrishnan Srikanth Chief Science &Techn. Officer | Award | Mar 02, 2026 | $0.00 | 175,000 | $0.00 | 345,736 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Mar 02, 2026 | $2,661.23 | 1,861 | $1.43 | 368,645 |
Lehman David Aaron GENERAL COUNSEL | Sell | Mar 02, 2026 | $6,339.19 | 4,433 | $1.43 | 247,396 |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sell | Mar 02, 2026 | $4,162.73 | 2,911 | $1.43 | 365,734 |
French Glendon E. III President and CEO | Sell | Mar 02, 2026 | $9,633.91 | 6,737 | $1.43 | 1.5M |
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Award | Mar 02, 2026 | $0.00 | 100,000 | $0.00 | 465,734 |
Lehman David Aaron GENERAL COUNSEL | Sell | Mar 02, 2026 | $3,703.70 | 2,590 | $1.43 | 244,806 |
French Glendon E. III President and CEO | Sell | Mar 02, 2026 | $83,466.24 | 58,368 | $1.43 | 1.4M |
Lehman David Aaron GENERAL COUNSEL | Sell | Mar 02, 2026 | $5,792.93 | 4,051 | $1.43 | 240,755 |
Lehman David Aaron GENERAL COUNSEL | Award | Mar 02, 2026 | $0.00 | 150,000 | $0.00 | 390,755 |
Williamson Steven S. PRESIDENT AND CEO | Sell | Sep 02, 2025 | $8,188.80 | 5,118 | $1.60 | 363,497 |